TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07089836: This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy

Sponsor: American Laboratory Products Company · Phase: PHASE2 · Area: INFECTIOUS_VACCINE · Target Enrollment: 1000 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$9,408,000

Rescue Site Savings

+$6,203,400

Unlock Full NCT07089836 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07089836 Rescue Dossier →